Pet Health

Galliprant (Grapiprant) for Dogs: Non-COX Osteoarthritis Triage

2 min read Updated Clinically reviewed • Standards
In this guide
Editorial policy
Health and Safety Boundary Jump to Emergency Red Flags ↓

This guide is general education for pet owners. If your pet has urgent symptoms, possible poisoning, injury, breathing trouble, collapse, severe pain, or sudden decline, contact a licensed veterinarian or local emergency service.

Editorial standard

How this guide was prepared

Edited for decisions NewsPet guides are structured around practical owner choices, tradeoffs, and safety boundaries.
Source policy Sources are listed when a guide relies on outside references.
Veterinary boundary This article does not diagnose or prescribe; urgent symptoms need veterinary care.
Corrections Readers can flag unclear, outdated, or inaccurate information through our contact page.

Galliprant (Grapiprant) for Dogs: Non-COX Osteoarthritis Triage

Clinical Classification & Indications

  • Drug Class: Piprant Class (Non-COX-Inhibiting Prostaglandin Receptor Antagonist)
  • Approved Uses: Control of pain and inflammation associated with mild to moderate canine osteoarthritis from early stages onwards.

Mechanism of Action (Pharmacodynamics)

Selectively blocks the EP4 prostaglandin receptor, the specific receptor primarily responsible for mediating osteoarthritic pain, without inhibiting COX enzymes and without suppressing protective homeostatic prostaglandins in kidneys and gut.

Commercial bottle of Galliprant 60mg grapiprant flavored tablets on stainless prep tray beside clinical EP4 receptor pharmacology leaflet
Figure 1: Pharmaceutical exhibit of Galliprant (grapiprant) 60 mg chewable tablets detailing the piprant-class targeted EP4 prostanoid receptor antagonist mechanism without systemic COX enzyme inhibition.

Adverse Reactions & Side Effect Profile

Common / Expected Side Effects
Vomiting, soft or mucous-coated stools, diarrhea, transient inappetence. Side effects are typically mild and self-limiting in the first 7 to 10 days of administration.

Emergency Red Flag Reactions
Persistent bloody diarrhea (hematochezia), continuous vomiting leading to severe dehydration, profound lethargy, or signs of protein-losing enteropathy.

Veterinary orthopedic surgeon assessing coxofemoral joint range of motion with medical plastic goniometer on senior Labrador Retriever
Figure 2: Clinical canine orthopedic range-of-motion assessment. Goniometric measurement of joint extension angles and capsular thickening to evaluate functional mobility recovery during targeted osteoarthritis therapy.

Clinical Contraindications & Interactions

  • Do Not Use In: Dogs weighing less than 8 lbs (3.6 kg), breeding/pregnant dogs, or dogs with pre-existing severe hepatic or cardiovascular conditions. Concurrent use with COX-inhibiting NSAIDs or systemic corticosteroids is strictly forbidden.

Strict Rule S1 Veterinary Prescription Directive

VETERINARY DIRECTIVE: Galliprant must be given once daily on an empty stomach (at least 1 hour before or 2 hours after a meal) for optimal absorption. While safer for liver and kidneys than traditional NSAIDs, routine veterinary monitoring remains standard of care. Never administer human pharmaceutical products or adjust dosages without direct examination and bloodwork by a licensed Doctor of Veterinary Medicine (DVM).

Printable tools

Download the matching worksheet

Continue Your Care Plan

Recommended next steps for your pet

Your Saved Guides

No guides saved yet. Click "Save guide" on any article to keep it here for quick access.